The 12 closest competitors and alternatives to b12 Labs among ai/ml companies — ranked by similarity to what b12 Labs actually does, not by market-cap band.
Subscribe to see b12 Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
B12 Labs provides an AI-powered software platform that automates and accelerates chemical synthesis for the pharmaceutical and biotechnology industries. Its tools assist researchers with retrosynthesis planning, reaction condition optimization, and the generation of execution-ready protocols for lab automation equipment.
b12 Labs is an ai/ml company headquartered in United States. Xcout tracks 2 named people at b12 Labs, including Zlatko Jončev (Co-Founder & CEO). Xcout recorded 1 job posting from b12 Labs in the last 90 days.
Xcout recorded 1 job posting from b12 Labs in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see b12 Labs's hiring signals →
Ranked by semantic similarity — how close each company is to b12 Labs by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar ai/ml company
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
Similar ai/ml company
Inductive Bio is a privately held biotechnology research organization focused on chemical intelligence for drug discovery. It developed Indy, an artificial intelligence chemistry assistant designed to aid medicinal chemists.
Artificial Intelligence & Biotechnology
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
AI Technologies, Computational Science, Drug Discovery, Biotechnology
AION Labs is a venture studio headquartered in Rehovot, Israel. It is dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development, connecting pharma R&D with new AI, technology, and scientific innovation.
Similar ai/ml company
Inceptive is a data-driven lab focused on AI medicines, creating tools for the rational design of novel biomolecules and biological software. The company has offices in Palo Alto, Berlin, and Zurich, and is pioneering the next generation of AI-driven medical advancements.
AI-driven Drug Discovery
Omec.AI is an Israeli startup founded in 2022 and headquartered in Rehovot, Israel, supported by AION Labs. The company is developing an AI-driven computational platform designed to help pharmaceutical researchers assess the clinical trial readiness of drug candidates by analyzing pre-clinical safety and efficacy data.
Biotech, AI/ML
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
Similar ai/ml company
BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
Similar ai/ml company
Medra is a privately held industry software development company headquartered in San Francisco, California. The company develops an autonomous scientific experimentation platform that combines artificial intelligence, robotics, and computer vision for continuous life science research.
AI-driven Drug Discovery
DenovAI Biotech Ltd is an Israeli biotechnology startup founded in 2023 and operated through the AION Labs venture studio in Rehovot. The company develops a generative AI and physics platform focused on the de novo design of novel proteins and therapeutic biologics.
Similar ai/ml company
BenchSci provides an AI-powered platform called EMET that assists biopharmaceutical researchers with preclinical drug discovery and disease biology research. The software integrates scientific data, literature, and analytical tools to support tasks such as target identification, experiment design, and lead optimization.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for b12 Labsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →